HUT61476A - Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification - Google Patents

Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification

Info

Publication number
HUT61476A
HUT61476A HU146091A HU146091A HUT61476A HU T61476 A HUT61476 A HU T61476A HU 146091 A HU146091 A HU 146091A HU 146091 A HU146091 A HU 146091A HU T61476 A HUT61476 A HU T61476A
Authority
HU
Hungary
Prior art keywords
hydrogen
carbonate
alkali
mixts
sodium
Prior art date
Application number
HU146091A
Other languages
Hungarian (hu)
Other versions
HU911460D0 (en
Inventor
David Greskovits
Dr Kenez Maria Davidne
Janos Pogany
Original Assignee
David Greskovits
Dr Kenez Maria Davidne
Janos Pogany
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Greskovits, Dr Kenez Maria Davidne, Janos Pogany filed Critical David Greskovits
Priority to HU146091A priority Critical patent/HUT61476A/en
Publication of HU911460D0 publication Critical patent/HU911460D0/en
Publication of HUT61476A publication Critical patent/HUT61476A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Dehydrating and simultaneously resalinating medicinal mixts. stabilised by alkali-hydrogen-carbonate(s) of new crystalline forms(s) contain: 90 (Sic-no units provided) sodium, 20 potassium, 80 chloride, 30 hydrogen carbonate, 110 glucose and/or water sol. salts of other metals pref 0.2-2.5 magnesium or calcium (or both in combination). The quoted values are to be dissolved in 1 dm/3 of water. Other overall quantities may be used provided m molar ratios are maintained in the mixts.. Alkali-hydrogen carbonates are present in these mixts. either as an isomorphic crystalline modification of carbon-dioxide satd. sodium-hydrogen-carbonate or as a heteromorphic, non-stoichiometric modification, obtd. from carbon dioxide satd. 0.25-2 mols of potassium-hydrogen-carbonate and 1 mol sodium-hydrogen-carbonate, by compressor. Alkali-hydrogen-carbonates are added to the mix in granular form of 177-841 micro-m. size; The size range of added anhydrous glucose is 250-1000 microns. Foregoing components are mixed with anhydrous alkali-chlorides and opt. flavouring and colouring agents, and are administered dissolved in water.
HU146091A 1991-05-02 1991-05-02 Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification HUT61476A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU146091A HUT61476A (en) 1991-05-02 1991-05-02 Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU146091A HUT61476A (en) 1991-05-02 1991-05-02 Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification

Publications (2)

Publication Number Publication Date
HU911460D0 HU911460D0 (en) 1991-11-28
HUT61476A true HUT61476A (en) 1993-01-28

Family

ID=10954581

Family Applications (1)

Application Number Title Priority Date Filing Date
HU146091A HUT61476A (en) 1991-05-02 1991-05-02 Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification

Country Status (1)

Country Link
HU (1) HUT61476A (en)

Also Published As

Publication number Publication date
HU911460D0 (en) 1991-11-28

Similar Documents

Publication Publication Date Title
KR850003355A (en) Platelet-type calcium carbonate powder and its manufacturing method
ES8306360A1 (en) Non hygroscopic salts of 4-hydroxy-butanoic acid, process for their preparation and their use for the manufacture of pharmaceutic agents.
TW349077B (en) Process for producing calcium carbonate particles having a size of 0.1 to 1.0 mu m
DE69405776D1 (en) Carboxymethylinulin
MY109531A (en) Effervescent antacid
MY101750A (en) Improvements in or relating to calcium salts.
HRP921482B1 (en) Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
CA2376017A1 (en) Potassium calcium citrate compositions and methods for production
GB1465635A (en) Methods for the synthesis of wollastonite
MY110367A (en) Process for preparing calcium sulphate
ATA130496A (en) PHARMACEUTICAL OR DIETETIC COMPOSITIONS
HUT61476A (en) Process for producing rehydrating pharmaceutical compositions stabilized with alkaline hydrogen carbonate of new crystalline modification
ES2029467T3 (en) PROCEDURE FOR OBTAINING AGENTS IN THE FORM OF A MELTING BLOCK CONTAINING ALKALINE HYDROXIDE AND, DUE TO THE CASE, ALSO ACTIVE CHLORINE FOR MECHANICAL CLEANING OF TABLEWARE.
CA2007260A1 (en) Effervescent analgesic antacid composition having reduced sodium content (ms-1569-cip-11)
CA2023493A1 (en) Composition for foaming preparation
CA2287464A1 (en) Method for producing calcium borate
LV5660A3 (en) Satisfaction with the acquisition of an antiviral agent
GB1376516A (en) Method for producing calcium sulphite
KR880009975A (en) compound
DK82088D0 (en) PREPARATION OF HYDROLYCIZED Zirconium Salt Substances and High Purity Zirconium Dioxide
JPS6245516A (en) Foamable bathing agent
GR3001567T3 (en) Process for the preparation of beta-hydroxybutyric acid and its salts by means of hydrolysis of oligomers of beta-hydroxybutyric acid in a basic medium
JPS6472916A (en) Production of baddeleyite type calcium carbonate
CA2045220A1 (en) Process for the production of chlorine dioxide
GB1184018A (en) Process for the preparation of Polyacyl Oxamidrazones

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee